Hottest Stocks in CW 39/21

Last week people traded for all it was worth on Find out here which stocks were bought and sold in particular large numbers and which motives were decisive for this.

Last week's hottest stocks - glasses with computer screen
Source: Kevin Ku,

Fear of Missing Out: Buying when prices rise

# Name Performance 7 days bought in this wikifolio, among others
1 Verbio 1,8% Refresh
2 CropEnergies 2,6% Nordstern
3 Gazprom (ADR) 2,4% Intelligent Invest World Markets
4 Abo Wind 3,6% The Greenvestor World
5 Zooplus 1,3% RS Handelssystem

The "Fear of Missing Out" – FOMO for short – leads traders to buy stocks whose price has already risen significantly. This trading motive could be observed last week with Verbio. Although the stock of the German biofuel producer lost value again and again last week, it was able to fight its way back each time. As Christian Mallek comments (SIGAVEST): "Yesterday's bout of weakness is already being bought again today. The medium- to long-term prospects are simply too good. We remain invested.” In his wikifolio VV Umwelt- und Klimatrends, the Verbio share is currently the largest portfolio position with a weighting of 5.7 percent.



Buying the Dip: Buys when prices fall

# Name Performance 7 days bought in this wikifolio, among others
1 BioNTech (ADR) -14,6% Goldesel Stockpicking USA
2 Encavis -8,8% Riu Trading
3 Home24 -9,4% SmallCap Dividende Plus
4 Align Technology -5,1% Amur Maackia
5 HelloFresh -1,8% firstclass stock picking

The "buying the dip" trading motive is evident when traders buy falling stocks in the hope of a bottoming out – in other words, the imminent turnaround. This is what happened last week at the vaccine manufacturer BioNTech last week. A detailed assessment of the situation is provided by Niels Hacker (NHWF) in the comments section of his wikifolio Multi Asset Strategies: "Reports from pharmaceutical company Merck of positive results from a study of the new Corona drug Molnupiravir have weighed on the stock prices of vaccine makers BioNTech and Moderna. In the coming weeks, Pfizer and BioNTech plan to seek emergency approval from the U.S. Food and Drug Administration (FDA) for their COVID-19 vaccine for children ages 5 to 11. That and possible booster vaccines in the fall and winter could give the stock a boost."



Key Figures

  • +100.1 %
    since 2020-03-12
  • -10.5 %
    1 Year
  • -
    Risk factor
  • EUR 323,711.96
    Invested capital

Taking Profit: Selling when prices are rising

The motive of "taking profit" – i.e. selling when prices are rising – could be observed last week at the pharmaceutical group Teva Pharm. Stock in the pharmaceutical company specializing in generic drugs gained significantly after it was announced that a court settlement had been reached in the protracted legal dispute with the U.S. State of Louisiana. Many traders took this opportunity and parted with the security.

Jumping the Ship: Selling when prices are falling

# Name Performance 7 days sold in this wikifolio, among others
1 Deutsche Post -3,1% PPinvest Searching Alpha
2 Aixtron -6,6% Trendfolge Long/Short Smallcap
3 Carl-Zeiss -10,0% Trendfollowing Deutschland
4 Moderna -15,9% FuTecUS
5 Adobe -3,6% Techwerte Invest

Selling when prices are falling – this is what characterizes the "Jumping the Ship" category. The same fate befell Deutsche Post last week. The logistics company's stock is currently losing value near its all-time high. Traders seem to suspect that this marks the end of the rally that has been ongoing since the Corona crash of 2020, or at least a pause, and are selling the security.

Would you like to have even more of a knowledge edge?

The latest insights of the wikifolio community are now directly available at the Trading Desk of the Stuttgart Stock Exchange.

Click here!

Disclaimer: Every investment in securities and other forms of investment is subject to various risks. Explicit reference is made to the risk factors in the prospectus documents of Lang & Schwarz Aktiengesellschaft (Final Terms, Base Prospectus together with supplements and the Simplified Prospectuses, respectively) at , and You should read the prospectus before making any investment decision in order to fully understand the potential risks and rewards of the decision to invest in the securities. The approval of the prospectus by the competent authority should not be construed as an endorsement of the securities offered or admitted to trading on a regulated market. The performance of the wikifolios as well as the respective wikifolio certificates refers to past performance. Future performance cannot be inferred from this. The content of this site does not constitute investment advice or a solicitation to buy or sell securities. This applies in particular to countries in which such an offer to buy or sell is not permitted. For further information, please refer to our General Terms and Conditions.